Overview

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

Summary

To test the hypothesis that the combination of the tincture of opium (DTO) and clonidine will be more effective in treating infants with neonatal abstinence syndrome (opioid withdrawal) than tincture of opium (DTO) alone.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

Johns Hopkins University

Treatments:

Clonidine